Table 2 Efficacy and safety data of the studies.
Study | Year | FMT(clinical remission) | Control(clinical remission) | FMT(endoscopic remission) | Control(endoscopic remission) | FMT(adverse reactions) | Control(adverse reactions) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Events | Total | Events | Total | Events | Total | Events | Total | Events | Total | Events | Total | ||
Kedia et al.8 | 2022 | 21 | 35 | 10 | 31 | 12 | 33 | 4 | 23 | 26 | 35 | 27 | 31 |
Sarbagili et al.9 | 2022 | 4 | 19 | 6 | 15 | 3 | 19 | 4 | 15 | NR | NR | NR | NR |
Haifer et al.10 | 2022 | 11 | 15 | 5 | 20 | 7 | 15 | 3 | 20 | 10 | 15 | 17 | 20 |
Crothers et al.11 | 2021 | 2 | 6 | 0 | 6 | NR | NR | NR | NR | 2 | 6 | 2 | 6 |
Březina et al.12 | 2021 | 12 | 21 | 8 | 22 | 3 | 21 | 3 | 22 | 12 | 21 | 13 | 22 |
Pai et al.13 | 2021 | 5 | 12 | 4 | 12 | NR | NR | NR | NR | 5 | 12 | 1 | 12 |
Fang et al.14 | 2021 | 9 | 10 | 5 | 10 | NR | NR | NR | NR | 0 | 10 | 0 | 10 |
Schierová et al.15 | 2020 | 3 | 8 | 4 | 8 | 1 | 8 | 3 | 8 | 0 | 8 | 0 | 8 |
Sood et al.16 | 2019 | 27 | 31 | 20 | 30 | 18 | 31 | 8 | 30 | 0 | 31 | 0 | 30 |
Costello et al.17 | 2019 | 18 | 38 | 6 | 35 | 4 | 38 | 0 | 35 | 3 | 38 | 2 | 35 |
Paramsothy et al.18 | 2017 | 18 | 41 | 8 | 40 | 5 | 41 | 3 | 40 | 32 | 41 | 33 | 40 |
Rossen et al.19 | 2015 | 7 | 17 | 5 | 20 | 8 | 17 | 9 | 20 | 18 | 23 | 16 | 25 |
Moayyedi et al.20 | 2015 | 9 | 38 | 2 | 37 | 9 | 38 | 2 | 37 | 3 | 38 | 2 | 37 |
